|
Report No. : |
316727 |
|
Report Date : |
09.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
THE MEDICAL EXPORT GROUP B.V. |
|
|
|
|
Registered Office : |
Papland 16, 4206CL Gorinchem |
|
|
|
|
Country : |
Netherlands |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
01.07.1980 |
|
|
|
|
Com. Reg. No.: |
23044580 |
|
|
|
|
Legal Form : |
Besloten Vennootschap |
|
|
|
|
Line of Business : |
Wholesale of medical and dental instruments (46462) |
|
|
|
|
No of Employees : |
54 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Netherlands |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
NETHERLANDS ECONOMIC OVERVIEW
Netherlands is the sixth-largest economy in the euro-zone and is noted for its stable industrial relations, moderate unemployment and inflation, sizable trade surplus, and important role as a European transportation hub. Industrial activity is predominantly in food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for the food-processing industry and for exports. Netherlands, along with 11 of its EU partners, began circulating the euro currency on 1 January 2002. The Dutch financial sector suffered as a result of the global financial crisis, due in part to the high exposure of some Dutch banks to US mortgage-backed securities. In 2008, the government nationalized two banks and injected billions of dollars of capital into other financial institutions, to prevent further deterioration of a crucial sector. After 26 years of uninterrupted economic growth, the Dutch economy - highly dependent on an international financial sector and international trade - contracted by 3.5% in 2009. To recover, the government sought to boost the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credit facilities. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE began implementing austerity measures in early 2011, mainly reducting expenditures, which resulted in an improved budget deficit in 2011. However, in 2012 tax revenues dropped, GDP contracted, and the budget deficit deteriorated. In 2013, the government budget deficit decreased to 3.3% of GDP due to increased government revenue from higher taxes. However, spending on social benefits also increased, due to a rise in unemployment benefits and payments for pensions. The high unemployment rate and tax increases have contributed to continued decreases in household disposable income, causing the Dutch economy to contract.
|
Source
: CIA |
Company name The Medical Export Group
B.V.
Operative address Papland 16
4206CL Gorinchem
Netherlands
Legal form Besloten
Vennootschap
Registration
number KvK-nummer: 23044580
VAT-number 005351261
|
Year |
2013 |
Mutation |
2012 |
Mutation |
2011 |
|
Fixed assets |
614.732 |
87,39 |
328.045 |
-4,52 |
343.570 |
|
Total receivables |
8.692.298 |
-35,84 |
13.547.508 |
181,25 |
4.816.932 |
|
Total equity |
6.587.065 |
19,67 |
5.504.519 |
46,85 |
3.748.449 |
|
Short term liabilities |
10.093.074 |
-31,90 |
14.821.514 |
210,01 |
4.780.970 |
|
Net result |
2.882.547 |
40,20 |
2.056.071 |
119,03 |
938.712 |
|
Working capital |
6.185.536 |
15,38 |
5.361.223 |
52,33 |
3.519.369 |
|
Quick ratio |
0,86 |
-5,49 |
0,91 |
-9,90 |
1,01 |
Company name The Medical Export
Group B.V.
Trade names The Medical Export
Group B.V.
Operative address Papland 16
4206CL Gorinchem
Netherlands
Correspondence
address Postbus 598
4200AN Gorinchem
Netherlands
Telephone number 0183 356100
Fax number 0183 356122
Email address info@meg.nl
Website www.meg.nl
Registration
number KvK-nummer:
23044580
Branch number 000020069634
VAT-number 005351261
Status Active
First registration
company register 1980-09-26
Memorandum 1980-09-05
Establishment date
1980-07-01
Legal form Besloten
Vennootschap
Last proposed
admendment 2004-10-28
Issued placed
capital EUR 349.581
Paid up share capital EUR 349.581
SBI Wholesale of
medical and dental instruments (46462)
Exporter Yes
Importer Yes
Branche
organisations TFCH - Task Force
Health Care
Goal Het verwerven van
orders in het buitenland ten behoeve van ondernemingen in de branche van
apparaten en gebruiksgoederen in ziekenhuizen, alsmede de handel in deze en
soortgelijke of aanverwante goederen
Accounts ABN
Amro Bank NV
Account number: 64.28.76.908
Active management C. te Kloese
(Christian)
Netherlands
Competence: Limited authorization
Function: Manager
Starting date: 2013-06-01
Date of birth: 1978-08-04, Naarden, NL
Movaria B.V.
Nassaulaan 55
3743CB BAARN
Netherlands
Registration number: 310359390000
Competence: Fully authorized
Function: General Director
Starting date: 1992-07-01
J.W. Maasland (Jan Willem)
Netherlands
Competence: Limited authorization
Function: Proxy
Starting date: 1998-06-30
Date of birth: 1955-03-09, Strijen, NL
M.F.G. Vos (Monica Francisca Geertruida)
Netherlands
Competence: Fully authorized
Function: Proxy
Starting date: 2007-05-01
Date of birth: 1969-10-28, Ubbergen, NL
G. Ranselaar (Guido)
Netherlands
Competence: Limited authorization
Function: Proxy
Starting date: 2013-06-01
Date of birth:
1974-02-12, Nijkerk, NL
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Total |
54 |
25 |
25 |
35 |
35 |
Score 6,89
Description The payments are
regular
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Quick ratio |
0,86 |
0,91 |
1,01 |
0,98 |
1,59 |
|
Current ratio |
1,61 |
1,36 |
1,74 |
1,57 |
2,65 |
|
Working capital/ balance total |
0,37 |
0,26 |
0,41 |
0,35 |
0,59 |
|
Equity / balance total |
0,39 |
0,27 |
0,43 |
0,37 |
0,62 |
|
Equity / Fixed assets |
10,72 |
16,78 |
10,91 |
10,79 |
13,26 |
|
Equity / liabilities |
0,64 |
0,37 |
0,77 |
0,60 |
1,64 |
|
Balance total / liabilities |
1,64 |
1,37 |
1,77 |
1,60 |
2,64 |
|
Working capital |
6.185.536 |
5.361.223 |
3.519.369 |
3.190.812 |
3.018.064 |
|
Equity |
6.587.065 |
5.504.519 |
3.748.449 |
3.409.737 |
3.160.830 |
|
Mutation equity |
19,67 |
46,85 |
9,93 |
7,87 |
3,88 |
|
Mutation short term liabilities |
-31,90 |
210,01 |
-14,87 |
207,23 |
-51,25 |
|
Return on total assets (ROA) |
22,68 |
13,29 |
14,31 |
15,24 |
29,16 |
|
Return on equity (ROE) |
58,17 |
49,51 |
32,99 |
40,78 |
46,91 |
|
Gross margin |
8.866.254 |
7.167.788 |
4.981.826 |
4.703.708 |
4.354.561 |
|
Operating result |
4.059.005 |
2.975.517 |
1.362.234 |
1.454.335 |
1.557.366 |
|
Net result after taxes |
2.882.547 |
2.056.071 |
938.712 |
1.048.907 |
1.118.202 |
|
Cashflow |
3.059.640 |
2.150.891 |
1.051.810 |
1.127.398 |
1.193.094 |
|
EBIT |
4.059.005 |
2.975.517 |
1.362.234 |
1.454.335 |
1.557.366 |
|
EBITDA |
4.236.098 |
3.070.337 |
1.475.332 |
1.532.826 |
1.632.258 |
|
Summary |
The 2013
financial result structure is a postive working captial of 6.185.536 euro, which
is in agreement with 37 % of the total assets of the company. The working
capital has increased with 15.38 % compared to previous year. The ratio, with
respect to the total assets of the company has however, increased. The improvement
between 2012 and 2013 has mainly been caused by an increase of the current
assets. The current
ratio of the company in 2013 was 1.61. A company with a current ratio
between1.5 and 3.0 generally indicates good short-term financial strength. The quick ratio
in 2013 of the company was 0.86. A company with a Quick Ratio of less than 1
cannot currently pay back its current liabilities. The 2012
financial result structure is a postive working captial of 5.361.223 euro,
which is in agreement with 26 % of the total assets of the company. The working
capital has increase with 52.33 % compared to previous year. The ratio with
respect to the total assets of the company has however, declined. The improvement
between 2011 and 2012 has mainly been caused by a current liabilities reduction. The current
ratio of the company in 2012 was 1.36. When the current ratio is below 1.5,
the company may have problems meeting its short-term obligations. The quick ratio
in 2012 of the company was 0.91. A company with a Quick Ratio of less than 1
cannot currently pay back its current liabilities |
Last annual
account 2013
Remark annual
account The company is
obliged to file its financial statements.
Type of annual
account Corporate
Annual account The Medical Export
Group B.V.
Papland 16
4206CL Gorinchem
Netherlands
Registration
number: 230445800000
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
End date |
2013-12-31 |
2012-12-31 |
2011-12-31 |
2010-12-31 |
2009-12-31 |
|
Tangible fixed assets |
614.732 |
328.045 |
343.570 |
316.104 |
238.409 |
|
Fixed assets |
614.732 |
328.045 |
343.570 |
316.104 |
238.409 |
|
Total stock |
7.578.679 |
6.629.639 |
3.451.139 |
3.316.914 |
1.939.062 |
|
Total receivables |
8.692.298 |
13.547.508 |
4.816.932 |
5.456.070 |
2.723.647 |
|
Liquid funds |
7.633 |
5.590 |
32.268 |
34.226 |
183.414 |
|
Current assets |
16.278.610 |
20.182.737 |
8.300.339 |
8.807.210 |
4.846.123 |
|
Total assets |
16.893.342 |
20.510.782 |
8.643.909 |
9.123.314 |
5.084.532 |
|
|
|
|
|
|
|
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
End date |
2013-12-31 |
2012-12-31 |
2011-12-31 |
2010-12-31 |
2009-12-31 |
|
Issued capital |
349.581 |
349.581 |
349.581 |
349.581 |
349.581 |
|
Other reserves |
3.354.938 |
3.098.867 |
2.460.156 |
2.011.249 |
2.811.249 |
|
Non-distributable profit |
2.882.546 |
2.056.071 |
938.712 |
1.048.907 |
|
|
Total reserves |
6.237.484 |
5.154.938 |
3.398.868 |
3.060.156 |
2.811.249 |
|
Total equity |
6.587.065 |
5.504.519 |
3.748.449 |
3.409.737 |
3.160.830 |
|
Provisions |
213.203 |
184.749 |
114.490 |
97.179 |
95.643 |
|
Short term liabilities |
10.093.074 |
14.821.514 |
4.780.970 |
5.616.398 |
1.828.059 |
|
Total short and long term liabilities |
10.306.277 |
15.006.263 |
4.895.460 |
5.713.577 |
1.923.702 |
|
Total liabilities |
16.893.342 |
20.510.782 |
8.643.909 |
9.123.314 |
5.084.532 |
|
Summary |
The total assets
of the company decreased with -17.64 % between 2012 and 2013. Despite the
total assets decrease, non current assets grew with 87.39 %. The asset reduction
is in contrast with the equity growth of 19.67 %. Due to this the total debt
decreased with -31.32 %. In 2013 the
assets of the company were 3.64 % composed of fixed assets and 96.36 % by
current assets. The assets are being financed by an equity of 38.99 %, and
total debt of 61.01 %. The total assets
of the company increased with 137.29 % between 2011 and 2012. Despite the
assets growth, the non current assets decreased with -4.52 %. The asset growth
has mainly been financed by a debt increase of 206.53 %. The Net Worth,
however, grew with 46.85 %. In 2012 the
assets of the company were 1.6 % composed of fixed assets and 98.4 % by
current assets. The assets are being financed by an equity of 26.84 %, and
total debt of 73.16 %. |
|
Year |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Gross margin |
8.866.254 |
7.167.788 |
4.981.826 |
4.703.708 |
4.354.561 |
|
Wages and salaries |
2.848.144 |
2.584.094 |
2.157.540 |
1.872.397 |
1.633.386 |
|
Amorization and depreciation |
177.093 |
94.820 |
113.098 |
78.491 |
74.892 |
|
other operating costs |
1.782.012 |
1.513.357 |
1.348.954 |
1.298.485 |
1.088.917 |
|
Operating expenses |
4.807.249 |
4.192.271 |
3.619.592 |
3.249.373 |
2.797.195 |
|
Operating result |
4.059.005 |
2.975.517 |
1.362.234 |
1.454.335 |
1.557.366 |
|
Financial income |
7.739 |
11.590 |
|
16.358 |
3.038 |
|
Financial expenses |
235.245 |
261.659 |
|
80.033 |
77.579 |
|
Financial result |
-227.506 |
-250.069 |
-125.663 |
-63.675 |
-74.541 |
|
Result on ordinary operations before taxes |
3.831.499 |
2.725.448 |
1.236.571 |
1.390.660 |
1.482.825 |
|
Taxation on the result of ordinary activities |
947.735 |
669.377 |
297.859 |
341.753 |
366.613 |
|
Result of ordinary activities after taxes |
2.883.764 |
2.056.071 |
938.712 |
1.048.907 |
1.116.212 |
|
Extraordinary income |
|
|
|
|
1.990 |
|
Extraordinary expense |
1.217 |
|
|
|
|
|
Extraordinary result after taxation |
-1.217 |
|
|
|
1.990 |
|
Net result |
2.882.547 |
2.056.071 |
938.712 |
1.048.907 |
1.118.202 |
|
Summary |
The gross profit
of the company grew with 23.7 % between 2012 and 2013. The operating
result of the company grew with 36.41 % between 2012 and 2013. This evolution
implies an increase of the company's economic profitability. The result of
these changes is an increase of the company's Economic Profitability of
70.65% of the analysed period, being equal to 2012 % in the year 2013. The Net Result
of the company decreased by 40.2 % between 2012 and 2013. The company's
Financial Profitability has been negatively affected by the financial
activities in comparison to the EBITs behaviour. The result of these
variations is a profitability reduction of 17.49 % of the analysed period,
being 58.17 % in the year 2013. The company's
financial structure has slowed down its financial profitability. The gross profit
of the company grew with 43.88 % between 2011 and 2012. The operating
result of the company grew with 118.43 % between 2011 and 2012. This
evolution implies an increase of the company's economic profitability. The result of
these changes is a reduction of the company's Economic Profitability of -7.13
% of the analysed period, being equal to 2011 % in the year 2012. The Net Result
of the company decreased by 119.03 % between 2011 and 2012. The company's
Financial Profitability has been negatively affected by the financial
activities in comparison to the EBITs behaviour. The result of these
variations is a profitability reduction of 50.08 % of the analysed period,
being 49.51 % in the year 2012. The company's financial structure has slowed down its financial
profitability. |
Branch (SBI) Wholesale trade
(no motor vehicles and motorcycles) (46)
Region Zuid-Holland Oost
In the Netherlands 109662 of the companies are registered with the SBI
code 46
In the region Zuid-Holland Oost 4943 of the companies are registered
with the SBI code 46
In the Netherlands 2387 of the bankrupcties are published within this
sector
In the region Zuid-Holland Oost 86 of the bankruptcies are published
within this sector
The risk of this specific sector in the Netherlands is normal
The risk of this
specific sector in the region Zuid-Holland Oost is normal
Filings 18-11-2014: De
jaarrekening over 2013 is gepubliceerd.
25-07-2013: De jaarrekening over 2012 is gepubliceerd.
20-07-2012: De jaarrekening over 2011 is gepubliceerd.
21-12-2011: De jaarrekening over 2010 is gepubliceerd.
06-08-2010: De jaarrekening over 2009 is gepubliceerd.
Functions 08-07-2013: Per
01-06-2013 is gevolmachtigde Guido Ranselaar in functie getreden.
28-06-2013: Per 01-06-2013 is gevolmachtigde Christian te Kloese in
functie getrede1n.
01-02-2013: Per 30-01-2013 is gevolmachtigde
Arnout van der Maas uit functie getreden.
Relations 4
Stichting
Administratiekantoor Movaria
Nassaulaan 55
3743CB BAARN
Netherlands
Registration
number: 320971780000
• Movaria B.V.
Nassaulaan 55
3743CB BAARN
Netherlands
Registration number:
310359390000
• The Medical
Export Group B.V.
Papland 16
4206CL Gorinchem
Netherlands
Registration number: 230445800000
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 62.32 |
|
|
1 |
Rs. 92.52 |
|
Euro |
1 |
Rs. 67.59 |
INFORMATION DETAILS
|
Analysis Done by
: |
RSM |
|
|
|
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.